SUVEN PHARMACEUTICALS
Back to Cashflow Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹358 Cr | ₹457 Cr | ₹330 Cr | ₹383 Cr | ₹407 Cr |
What is the latest Cash Flow from Operating Activities ratio of SUVEN PHARMACEUTICALS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹358 Cr |
Mar2023 | ₹457 Cr |
Mar2022 | ₹330 Cr |
Mar2021 | ₹383 Cr |
Mar2020 | ₹407 Cr |
How is Cash Flow from Operating Activities of SUVEN PHARMACEUTICALS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹358 Cr | -21.59 | |
Mar2023 | ₹457 Cr | 38.54 | |
Mar2022 | ₹330 Cr | -13.74 | |
Mar2021 | ₹383 Cr | -5.99 | |
Mar2020 | ₹407 Cr | - |
Compare Cash Flow from Operating Activities of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹38,164.4 Cr | -3.8% | 3.9% | 12.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,273.0 Cr | 2.5% | 4.1% | -0.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,604.0 Cr | 0.5% | -2.9% | 35.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,316.0 Cr | 6.2% | 9.3% | 17.9% | Stock Analytics | |
CIPLA | ₹125,993.0 Cr | 4.9% | 2.9% | 1.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,795.0 Cr | 2.1% | 1.2% | -5% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | -3.8% |
3.9% |
12.9% |
SENSEX | -1.5% |
-2.5% |
0.2% |
You may also like the below Video Courses